Brookmont Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
15,962
+300
+2% +$21.9K 0.57% 41
2026
Q1
$1.2M Buy
15,662
+721
+5% +$52K 0.67% 37
2025
Q4
$954K Sell
14,941
-107
-0.7% -$6.59K 0.55% 39
2025
Q3
$949K Sell
15,048
-77
-0.5% -$5.37K 0.53% 36
2025
Q2
$1.13M Sell
15,125
-284
-2% -$22.3K 0.65% 37
2025
Q1
$1.36M Sell
15,409
-545
-3% -$51.5K 0.77% 32
2024
Q4
$1.46M Sell
15,954
-332
-2% -$34K 0.78% 33
2024
Q3
$1.82M Sell
16,286
-564
-3% -$56.4K 0.94% 31
2024
Q2
$1.65M Sell
16,850
-701
-4% -$69.6K 0.9% 30
2024
Q1
$1.76M Buy
17,551
+271
+2% +$23.8K 0.93% 30
2023
Q4
$1.55M Sell
17,280
-513
-3% -$40.9K 0.87% 31
2023
Q3
$1.37M Sell
17,793
-97
-0.5% -$8.05K 0.85% 29
2023
Q2
$1.5M Sell
17,890
-10
-0.1% -$813 0.9% 31
2023
Q1
$1.51M Sell
17,900
-41
-0.2% -$3.52K 0.95% 31
2022
Q4
$1.46M Sell
17,941
-7,573
-30% -$610K 0.9% 31
2022
Q3
$1.81M Buy
25,514
+1,914
+8% +$172K 1.26% 29
2022
Q2
$2.12M Buy
23,600
+164
+0.7% +$17K 1.46% 29
2022
Q1
$2.63M Buy
23,436
+231
+1% +$27.1K 1.58% 24
2021
Q4
$2.81M Sell
23,205
-825
-3% -$91.7K 1.48% 24
2021
Q3
$2.42M Buy
+24,030
New +$2.65M 1.43% 28

Other funds holding EMN

Brookmont Capital Management's EMN Position: Q2 2026 in Review

Brookmont Capital Management increased its Eastman Chemical (EMN) stake by 1.9% in Q2 2026, buying an estimated $21.9K and bringing the position to 15,962 shares worth $1.07M. The position accounts for 0.57% of the portfolio, ranked #41.

Brookmont Capital Management first reported a position in EMN in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.81M in Q4 2021. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Brookmont Capital Management held 15,962 shares of Eastman Chemical worth $1.07M as of Q2 2026.
  • Brookmont Capital Management bought 300 Eastman Chemical shares in Q2 2026, an estimated $21.9K.
  • Eastman Chemical made up 0.57% of Brookmont Capital Management's portfolio in Q2 2026, its #41 holding.
  • Brookmont Capital Management first reported a position in Eastman Chemical in Q3 2021 and has held it in 20 quarters since.
  • Brookmont Capital Management's Eastman Chemical position peaked at $2.81M in Q4 2021.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Brookmont Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.